Clinical Trial Update: Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy

View source ↗

Summary

Clinical trial update reporting immune responses in prostate, lung, melanoma, and breast cancer patients after SBRT, IMRT, or brachytherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Melanoma
• Prostate Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Cancer, Breast Cancer | Status: COMPLETED